{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:46:16Z","timestamp":1763621176144,"version":"3.37.3"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2021R1I1A2047475"],"award-info":[{"award-number":["NRF- 2021R1I1A2047475"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ijsu.2022.106753","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:40:50Z","timestamp":1656999650000},"page":"106753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Han Ah","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Seok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-3511","authenticated-orcid":false,"given":"In-Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Sup","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-4588","authenticated-orcid":false,"given":"Chai Hong","family":"Rim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"6","key":"10.1016\/j.ijsu.2022.106753_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA"},{"issue":"9822","key":"10.1016\/j.ijsu.2022.106753_bib2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijsu.2022.106753_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2147\/CMAR.S193761","article-title":"Role of local treatment including radiotherapy in Barcelona Clinic of Liver Cancer stage C patients: a nationwide cohort analysis in South Korea","volume":"11","author":"Lee","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ijsu.2022.106753_bib4","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.2147\/OTT.S104307","article-title":"The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus","volume":"9","author":"Bai","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.17998\/jlc.21.1.58","article-title":"Hepatocellular carcinoma in Korea: an analysis of the 2015 Korean nationwide cancer registry","volume":"21","author":"Yoon","year":"2021","journal-title":"J Liver Cancer"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106753_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3350\/cmh.2016.22.1.160","article-title":"Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"22","author":"Lee","year":"2016","journal-title":"Clin. Mol. Hepatol."},{"issue":"26","key":"10.1016\/j.ijsu.2022.106753_bib10","doi-asserted-by":"crossref","first-page":"e3959","DOI":"10.1097\/MD.0000000000003959","article-title":"Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus","volume":"95","author":"Zheng","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"19","key":"10.1016\/j.ijsu.2022.106753_bib11","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1002\/cncr.26561","article-title":"Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"118","author":"Peng","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ijsu.2022.106753_bib12","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1245\/s10434-014-3510-3","article-title":"Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis","volume":"21","author":"Liu","year":"2014","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ijsu.2022.106753_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-021-03632-4","article-title":"Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma","author":"Han","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106753_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biology10040326","article-title":"On behalf of the Korean liver cancer study G. Benefits of local treatment including external radiotherapy for hepatocellular carcinoma with portal invasion","volume":"10","author":"Lee","year":"2021","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2017.11.013","article-title":"Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic review","volume":"129","author":"Rim","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ijsu.2022.106753_bib16","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2147\/OTT.S164651","article-title":"Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials","volume":"11","author":"Rim","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"8","key":"10.1016\/j.ijsu.2022.106753_bib17","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.21873\/anticanres.12808","article-title":"Treatment of na\u00efve HCC combined with segmental or subsegmental portal vein tumor thrombosis: liver resection versus TACE followed by radiotherapy","volume":"38","author":"Yu","year":"2018","journal-title":"Anticancer Res."},{"issue":"9","key":"10.1016\/j.ijsu.2022.106753_bib18","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1002\/cam4.1708","article-title":"Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus","volume":"7","author":"Su","year":"2018","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106753_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3350\/cmh.2017.0041","article-title":"Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion","volume":"24","author":"Lee","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"issue":"11","key":"10.1016\/j.ijsu.2022.106753_bib20","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1245\/s10434-018-6653-9","article-title":"Downstaging with localized concurrent chemoradiotherapy can identify optimal surgical candidates in hepatocellular carcinoma with portal vein tumor thrombus","volume":"25","author":"Chong","year":"2018","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ijsu.2022.106753_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.radonc.2019.05.006","article-title":"Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: an open-label randomized controlled trial","volume":"140","author":"Sun","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"24","key":"10.1016\/j.ijsu.2022.106753_bib22","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.18.02184","article-title":"Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study","volume":"37","author":"Wei","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijsu.2022.106753_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijsu.2017.06.082","article-title":"Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: a retrospective cohort study","volume":"44","author":"Hamaoka","year":"2017","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijsu.2022.106753_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijsu.2022.106753_bib25","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ijsu.2022.106753_bib26","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (Updated February 2021). Cochrane","article-title":"Chapter 4: searching for and selecting studies","author":"Lefebvre","year":"2021"},{"key":"10.1016\/j.ijsu.2022.106753_bib27","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (Updated February 2021). Cochrane","article-title":"Chapter 24: including non-randomized studies on intervention effects","author":"Reeves","year":"2021"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106753_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3748\/wjg.v26.i4.393","article-title":"Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: diverse global viewpoints","volume":"26","author":"Park","year":"2020","journal-title":"World J. Gastroenterol."},{"year":"2011","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"Peterson","key":"10.1016\/j.ijsu.2022.106753_bib30"},{"year":"2019","series-title":"Ch 24.6: Synthesis of Results from Non-randomized Studies","author":"Higgins","key":"10.1016\/j.ijsu.2022.106753_bib31"},{"issue":"14","key":"10.1016\/j.ijsu.2022.106753_bib32","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1200\/jco.2004.22.90140.6098","article-title":"The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials","volume":"22","author":"Colevas","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijsu.2022.106753_bib33","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106753_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"year":"2019","series-title":"Ch 24.5: Assessing Risk of Bias in Non-randomized Studies","author":"Higgins","key":"10.1016\/j.ijsu.2022.106753_bib35"},{"year":"2019","series-title":"Ch 9.5.4 Incorporating Heterogeneity into Random-Effects Models","author":"Higgins Jt","key":"10.1016\/j.ijsu.2022.106753_bib36"},{"issue":"7109","key":"10.1016\/j.ijsu.2022.106753_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106753_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel\u2010plot\u2013based method of testing and adjusting for publication bias in meta\u2010analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.ijsu.2022.106753_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cegh.2018.05.005","article-title":"Interpretation of subgroup analyses in systematic reviews: a tutorial","volume":"7","author":"Richardson","year":"2019","journal-title":"Clin Epidemiol Global Health"},{"issue":"4","key":"10.1016\/j.ijsu.2022.106753_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4143\/crt.2018.687","article-title":"Treatment outcome after fractionated conformal radiotherapy for hepatocellular carcinoma in patients with child-pugh classification B in Korea (KROG 16-05)","volume":"51","author":"Bae","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijsu.2022.106753_bib41","first-page":"403","article-title":"Appraisal of long-term outcomes of liver-directed concurrent chemoradiotherapy for hepatocellular carcinoma with major portal vein invasion","volume":"7","author":"Han","year":"2020","journal-title":"J Hepatocel"},{"key":"10.1016\/j.ijsu.2022.106753_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ctro.2017.04.003","article-title":"Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"4","author":"Holliday","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-017-0873-1","article-title":"Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study","volume":"12","author":"Kim","year":"2017","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ijsu.2022.106753_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.08.009","article-title":"Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: necessity to subclassify Barcelona Clinic Liver Cancer stage C","volume":"141","author":"Kim","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"36","key":"10.1016\/j.ijsu.2022.106753_bib45","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.25224","article-title":"Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ijsu.2022.106753_bib46","first-page":"11626","article-title":"Prognostic factors in cases of radiotherapy to portal vein tumor thrombus in advanced hepatocellular carcinoma: a 8-year retrospective study","volume":"10","author":"Meng","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"13","key":"10.1016\/j.ijsu.2022.106753_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019660","article-title":"Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"99","author":"Que","year":"2020","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-018-1136-5","article-title":"Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis","volume":"13","author":"Shui","year":"2018","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ijsu.2022.106753_bib49","article-title":"Jiedu granule combined with transcatheter arterial chemoembolization and gamma knife radiosurgery in treating hepatocellular carcinoma with portal vein tumor thrombus","author":"Wang","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"11","key":"10.1016\/j.ijsu.2022.106753_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003015","article-title":"Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.ijsu.2022.106753_bib51","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.2147\/OTT.S113161","article-title":"Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus","volume":"9","author":"Wu","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-019-1382-1","article-title":"Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis","volume":"14","author":"Yang","year":"2019","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-8-351","article-title":"Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis","volume":"8","author":"Choi","year":"2008","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jrr\/rrt082","article-title":"Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy","volume":"55","author":"Choi","year":"2014","journal-title":"J. Radiat. Res."},{"issue":"7","key":"10.1016\/j.ijsu.2022.106753_bib55","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1440-1746.2011.06745.x","article-title":"Efficacy of therapy for advanced hepatocellular carcinoma: intra\u2010arterial 5\u2010fluorouracil and subcutaneous interferon with image\u2010guided radiation","volume":"26","author":"Chuma","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106753_bib56","first-page":"59","article-title":"Preliminary results of three-dimensional conformal radiotherapy for hepatocellular carcinoma with portal vein thrombosis","volume":"27","author":"Hsu","year":"2002","journal-title":"Chin. J. Radiol."},{"issue":"4","key":"10.1016\/j.ijsu.2022.106753_bib57","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijrobp.2008.06.1486","article-title":"The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma","volume":"73","author":"Huang","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106753_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00000421-200204000-00019","article-title":"Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus","volume":"25","author":"Ishikura","year":"2002","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/mco.2013.196","article-title":"Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2","author":"Kang","year":"2014","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"10.1016\/j.ijsu.2022.106753_bib60","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.coc.0000239147.60196.11","article-title":"Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable","volume":"29","author":"Kim","year":"2006","journal-title":"Am. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106753_bib61","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3857\/roj.2014.32.3.170","article-title":"Three-dimensional conformal radiotherapy for portal vein tumor thrombosis alone in advanced hepatocellular carcinoma","volume":"32","author":"Lee","year":"2014","journal-title":"Radiat. Oncol. J"},{"issue":"4","key":"10.1016\/j.ijsu.2022.106753_bib62","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/01.COC.0000077936.97997.AB","article-title":"Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma","volume":"26","author":"Li","year":"2003","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1754-9485.12207","article-title":"A comparison between three\u2010dimensional conformal radiotherapy combined with interventional treatment and interventional treatment alone for hepatocellular carcinoma with portal vein tumour thrombosis","volume":"59","author":"Lu","year":"2015","journal-title":"J Med Imag Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib64","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jrr\/rrw028","article-title":"Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis\/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy","volume":"57","author":"Matsuo","year":"2016","journal-title":"J. Radiat. Res."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-14-84","article-title":"Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis","volume":"14","author":"Nakazawa","year":"2014","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12072-014-9592-y","article-title":"Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion","volume":"9","author":"Onishi","year":"2015","journal-title":"Hepatol Int"},{"issue":"8","key":"10.1016\/j.ijsu.2022.106753_bib67","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jjco\/hys082","article-title":"Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis","volume":"42","author":"Rim","year":"2012","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib68","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.17554\/j.issn.2224-3992.2015.04.502","article-title":"Cutoff values for dose-liver function parameters to prevent radiation-induced liver disease in advanced hepatoma","volume":"4","author":"Shirai","year":"2015","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"6","key":"10.1016\/j.ijsu.2022.106753_bib69","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s00268-013-1969-x","article-title":"Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study","volume":"37","author":"Tang","year":"2013","journal-title":"World J. Surg."},{"issue":"6","key":"10.1016\/j.ijsu.2022.106753_bib70","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1440-1746.2001.02496.x","article-title":"Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement","volume":"16","author":"Tazawa","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ijsu.2022.106753_bib71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2007.07.005","article-title":"Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma","volume":"84","author":"Toya","year":"2007","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063864","article-title":"Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombosis","volume":"8","author":"Xi","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0360-3016(03)00434-6","article-title":"Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma","volume":"57","author":"Yamada","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib74","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ijrobp.2011.03.019","article-title":"Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes","volume":"82","author":"Yoon","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.ijsu.2022.106753_bib75","first-page":"1014","article-title":"Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy","volume":"26","author":"Yu","year":"2011","journal-title":"JKMS"},{"issue":"6","key":"10.1016\/j.ijsu.2022.106753_bib76","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/cncr.24139","article-title":"Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3\u2010dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization","volume":"115","author":"Zhang","year":"2009","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.ijsu.2022.106753_bib77","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8642","article-title":"Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib78","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/hep.30490","article-title":"An eastern hepatobiliary surgery hospital\/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus: a multicenter study","volume":"69","author":"Zhang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ijsu.2022.106753_bib79","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S278777","article-title":"The prognostic comparison between hepatocellular carcinoma with portal vein tumor thrombus and bile duct cancer thrombus after liver resection","volume":"12","author":"Yang","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"20","key":"10.1016\/j.ijsu.2022.106753_bib80","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-6181","article-title":"Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial","volume":"8","author":"Sun","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"9","key":"10.1016\/j.ijsu.2022.106753_bib81","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1002\/cam4.1708","article-title":"Comparison of three\u2010dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus","volume":"7","author":"Su","year":"2018","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3349\/ymj.2021.62.1.29","article-title":"Comparison of liver transplantation and liver resection for hepatocellular carcinoma patients with portal vein tumor thrombus type I and type II","volume":"62","author":"Lv","year":"2021","journal-title":"Yonsei Med. J."},{"issue":"15","key":"10.1016\/j.ijsu.2022.106753_bib83","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.3748\/wjg.v22.i15.4034","article-title":"Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma","volume":"22","author":"Li","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib84","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jhep.2016.05.044","article-title":"Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion","volume":"65","author":"Kokudo","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijsu.2022.106753_bib85","first-page":"1","article-title":"Prognostic accuracy of the ADV score following resection of hepatocellular carcinoma with portal vein tumor thrombosis","author":"Hwang","year":"2020","journal-title":"J. Gastrointest. Surg."},{"issue":"9","key":"10.1016\/j.ijsu.2022.106753_bib86","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jhbp.574","volume":"25","author":"Hatano","year":"2018","journal-title":"J Hepatobil Pancreat Sci"},{"issue":"16","key":"10.1016\/j.ijsu.2022.106753_bib87","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1002\/cam4.2556","article-title":"Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: a propensity score\u2010matched survival analysis","volume":"8","author":"Gao","year":"2019","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib88","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12072-020-10032-2","article-title":"Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study","volume":"14","author":"Chen","year":"2020","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.ijsu.2022.106753_bib89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.21037\/tcr.2016.11.78","article-title":"Analysis of surgical treatment and prognostic factors for hepatocellular carcinoma with portal vein tumor thrombus","volume":"6","author":"Cao","year":"2017","journal-title":"Transl. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijsu.2022.106753_bib90","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1754-9485.12948","article-title":"Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta\u2010analyses","volume":"63","author":"Rim","year":"2019","journal-title":"J Med Imag Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib91","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.ijsu.2022.106753_bib92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMra1614394","article-title":"Evidence for health decision making\u2014beyond randomized, controlled trials","volume":"377","author":"Frieden","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijsu.2022.106753_bib93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/medicina57020117","article-title":"Updating perspectives on meta-analyses in the field of radiation oncology","volume":"57","author":"Shin","year":"2021","journal-title":"Medicina"},{"issue":"16","key":"10.1016\/j.ijsu.2022.106753_bib94","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ijsu.2022.106753_bib95","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/aje\/kwm189","article-title":"Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles","volume":"166","author":"Shrier","year":"2007","journal-title":"Am. J. Epidemiol."}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919122005301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919122005301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:08:56Z","timestamp":1677082136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919122005301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":95,"alternative-id":["S1743919122005301"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2022.106753","relation":{},"ISSN":["1743-9191"],"issn-type":[{"type":"print","value":"1743-9191"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2022.106753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106753"}}